Cure My Disease

Don't miss your cure!

 Log in / Sign up

3D-Printed seat aims to boost daily life for kids with movement disorders

NCT ID NCT07330921

Symptom relief Sponsor: Instituto de Investigación Sanitaria Aragón Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests a new 3D-printed seating system (SSAP3D) designed for children aged 2-6 with neuromotor dysfunction. The goal is to see if the custom seat improves their ability to perform daily activities and participate at home, school, and in the community. Twelve children will try both the new seat and their usual seating system for six weeks each, and families will report on changes in function and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 6 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Medical Situation of Neuromotor Disfunction * Be user of some type of adapted seating system * Age between 2-6 years * Have head control levels of 3 to 8 on the Level of Sitting Scale (LSS) * Be able to maintain a standing position for at least 10 seconds, with or without external assistance. Exclusion Criteria: * Presenting moderate or severe cognitive impairment, which generates significant difficulties in understanding the instructions given by the evaluator * Having suffered a traumatic injury o surgical process in the 6 months prior to the start of the study or during the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromotor dysfunction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromotor dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AIDIMO (Asociación para la Investigación en la Discapacidad Motriz)

    RECRUITING

    Zaragoza, Zaragoza, 50011, Spain